DIABETES SEMINARMAY 14-20, 2017

Schloss Arenberg Salzburg, Austria

TESTIMONIALS FROM FELLOWS

• After attending the DM seminar lectures, I found it more important to work on prevention, screening and early detection of diabetic patients since almost half of the patients don’t even know they are diabetic. For me, it was an amazing experience to attend and inter-act with the seminar over this week.

• I want to mention that all the fellows are so intelligent and experienced in different fields of diabetes, so we could share our experience and share new knowledge with each other. All the faculty members are so open and ready to help and discuss different diabetes relat-ed topics.

• The seminar was excellently prepared. I appreciate very much the possibility of going through the lectures once more because of our CD.

• I am more motivated to spend as much time as possi-ble with my patients, trying to understand their way of life in order to find a treatment that fits best.

• The seminar improved my skills to assess patients with diabetes and ulcerations (especially foot ulcerations). Also it improved my skills to teach my younger col-leagues.

• It was very informative, simple to understand, and there were a lot of cracticial tips that we can use in our practice. The lectures also cover all the main aspects of diabetology.

Open Medical Institute Arenbergstrasse 10

5020 Salzburg, AustriaPhone: +43 662 640 101

Fax: +43 662 640 101 110salzburg-office@openmedicalinstitute.org

www.aaf-online.org

a program of the

ABOUT THE OMI SEMINARS

The Open Medical Institute (OMI) is a global educational initia-tive founded in 1993 by The American Austrian Foundation and physicians from Weill Cornell Medical College. In the meantime, leading US and European institutions, including Weill Cornell Me-dical College and affiliated hospitals, The Children’s Hospital of Philadelphia, Duke University Medical Center, Cleveland Clinic Foundation, The College of Physicians and Surgeons of Columbia University and the Medical Universities of Vienna, Graz and Inns-bruck have joined the initiative and provide the academic leader-ship for the seminars, with all faculty members serving pro bono. The mission is to share medical knowledge with doctors and health care providers from countries in transition, and foster their profes-sional growth and at the same time prevent brain drain. The OMI is run under the auspices of The American Austrian Foundation and is co-funded by the Austrian Federal Government and other private and public institutions, corporations and individuals.

ABOUT THE OMI DIABETES SEMINARWorldwide, 422 Million adults are suffering from Dia-betes and the global prevalence of diabetes has nearly doubled since 1980, rising to 8.5% in the adult popula-tion, according to the World Health Organization . The Open Medical Institute (OMI) has therefore put a focus on cardiovascular diseases and diabetes and started an annual Diabetes Seminar in collaboration with Colum-bia University, in New York, USA, Heinrich-Heine Uni-versity in Düsseldorf, Germany and the University of Belgrade, Serbia.

The aim of the Diabetes Seminar is to inform doctors around the world about the state-of-the-art in diagnostics and treatment of diabetes. At the same time, the Seminar is a great opportunity for the participants to discuss their cases with internationally recognized experts in diabetes and endocrinology and to exchange their experiences with other colleagues.

The Seminars target at young and mid-career level me-dical doctors who deal with diabetes-patients and are interested in research and teaching other colleagues and students.

If you are a medical doctor, have finished your residen-cy (or are in your last year of residency training), have an interest in diabetes, endocrinology or lipid metabo-lism, and speak English fluently, you can apply through: http://www.aaf-online.org/index.php/how-to-apply.html. Participants are selected based on their qualifica-tions and attend on scholarship.

Wolfgang Aulitzky, MDDirector, Open Medical Institute

DIABETES SEMINAR 2017 – SPEAKERS AND TOPICS

Speakers Topics

Robin S. Goland, MD • History of DiabetesJ. Merrill Eastman Professor; Medicine and Pediatrics; • Pathophysiology Type 1 DiabetesColumbia University Endocrinologist and Co-Director;Naomi Berrie Diabetes CenterNew York, USA

Nebojsa M. Lalic, MD, PhD • Diabetes Prevention and Pre-DiabetesProfessor of Internal Medicine; • Insulin and Incretins for Type 2 DiabetesSchool of Medicine, University of Belgrade • Microvascular Complications of DiabetesHead of the Center for Metabolic Disorders,Intensive Treatment and Cell Therapy in Diabetes,Institute for Endocrinology, Diabetes and Metabolic Diseases;Clinical Center of SerbiaSerbia, Belgrade

Natasha Leibel, MD • Insulin Pumps and Glucose SensorsAssistant Professor of Clinical Medicine, Division of Endocrinology • Unusual Diabetes and Related SyndromesColumbia University • DKA and Hyperosmolar ComaNew York, USA

Utpal B. Pajvani, MD, PhD • Obesity: Causes and TreatmentsAssistant Professor of Clinical Medicine, Division of Endocrinology • Oral Agents in Type 2 DiabetesColumbia University • Cardiovascular Disease DiabetesNew York, USA • Recent Controversies in Type 2 Diabetes

Prof. Dr. Michael Roden • Pathophysiology Type 2 DiabetesScientific Director, • Obesity-related Liver DiseaseDeutsches Diabetes-Zentrum DDZ (German Diabetes Center) • Foot ComplicationsProfessor of Medicine & Director,Department of Metabolic Diseases;Heinrich-Heine UniversityDüsseldorf, Germany

Matthew Freeby, MD • Insulin Treatment of Type 1 DiabetesAssistant Clinical Professor of Medicine, • Diabetes and PregnancyDirector of the Gonda Diabetes Center, • Diabetes in Hospitalized PatientsAssociate Director of Diabetes Clinical ProgramsLos Angeles, California, USA